Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Longer Duration of Treatment with ICIs Associated with a Higher Rate...

Ogkologos - 5 Μαρτίου, 2025

Scientists Find Genetic Changes Linked to Cancer in Children

Ogkologos - 4 Μαρτίου, 2025

Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear...

Ogkologos - 4 Μαρτίου, 2025

Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or...

Ogkologos - 3 Μαρτίου, 2025

EMA Recommends Extension of Therapeutic Indications for Lisocabtagene Maraleucel

Ogkologos - 28 Φεβρουαρίου, 2025

FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic, Hormone Receptor-positive, HER2-negative...

Ogkologos - 27 Φεβρουαρίου, 2025

Can AI Help Predict Which Cancer Patients Should Be Treated with...

Ogkologos - 26 Φεβρουαρίου, 2025

Strong Independent Association of TILs with OS for Patients with ERBB2-positive...

Ogkologos - 26 Φεβρουαρίου, 2025

Acalabrutinib-Venetoclax With or Without Obinutuzumab Significantly Prolongs PFS in Fit Patients...

Ogkologos - 25 Φεβρουαρίου, 2025

ESMO Targeted Anticancer Therapies Congress 2025, Paris, France, 3-5 March

Ogkologos - 24 Φεβρουαρίου, 2025

1...565758...440 Σελίδα 57 από 440

MOST POPULAR

Lawmaker Dad Raises Awareness For RSV, An Illness He’d Never Heard...

20 Νοεμβρίου, 2019

Predicting future breast cancer with precision

22 Μαρτίου, 2021

Dame Deborah James: why do deeply personal stories resonate with us...

24 Μαΐου, 2022

Registry Findings Highlight the Importance of Interdisciplinary Care in Rheumatic irAEs...

21 Σεπτεμβρίου, 2020

Φόρτωση περισσοτέρων

Longer Duration of Treatment with ICIs Associated with a Higher Rate...

Scientists Find Genetic Changes Linked to Cancer in Children

Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear...

Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or...

EMA Recommends Extension of Therapeutic Indications for Lisocabtagene Maraleucel

FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic, Hormone Receptor-positive, HER2-negative...

Can AI Help Predict Which Cancer Patients Should Be Treated with...

Strong Independent Association of TILs with OS for Patients with ERBB2-positive...

Acalabrutinib-Venetoclax With or Without Obinutuzumab Significantly Prolongs PFS in Fit Patients...

ESMO Targeted Anticancer Therapies Congress 2025, Paris, France, 3-5 March

MOST POPULAR

Lawmaker Dad Raises Awareness For RSV, An Illness He’d Never Heard...

Predicting future breast cancer with precision

Dame Deborah James: why do deeply personal stories resonate with us...

Registry Findings Highlight the Importance of Interdisciplinary Care in Rheumatic irAEs...

HOT NEWS

The future of dMMR/MSI-H locally advanced rectal cancer could be free...

FDA Approves Durvalumab for Muscle Invasive Bladder Cancer

Four randomized prospective degree compared 90 days regarding neoadjuvant ADT observed...

Weak Immunogenicity in Patients with Cancer After First Dose of mRNA-based...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ